Technical Analysis for IDYA - IDEAYA Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 37.59 | 1.24% | 0.46 |
IDYA closed up 1.24 percent on Monday, April 22, 2024, on 1.14 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 1.24% | |
| Below Lower BB | Weakness | 1.24% | |
| Down 3 Days in a Row | Weakness | 1.24% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 17 hours ago |
| Up 3% | about 17 hours ago |
| 60 Minute Opening Range Breakout | about 18 hours ago |
| Up 2% | about 18 hours ago |
| Rose Above Lower Bollinger Band | about 20 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
IDEAYA is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies IDEAYA is developing. IDEAYA is applying these capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality – which represents an emerging class of precision medicine targets.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Drug Discovery Medical Genetics Biomarkers Medical Test Precision Medicine Molecular Diagnostics Targeted Therapy Systems Biology Synthetic Lethality
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Drug Discovery Medical Genetics Biomarkers Medical Test Precision Medicine Molecular Diagnostics Targeted Therapy Systems Biology Synthetic Lethality
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.735 |
| 52 Week Low | 18.0872 |
| Average Volume | 688,287 |
| 200-Day Moving Average | 33.45 |
| 50-Day Moving Average | 43.72 |
| 20-Day Moving Average | 41.48 |
| 10-Day Moving Average | 40.55 |
| Average True Range | 1.74 |
| RSI (14) | 32.43 |
| ADX | 22.89 |
| +DI | 11.67 |
| -DI | 30.62 |
| Chandelier Exit (Long, 3 ATRs) | 41.18 |
| Chandelier Exit (Short, 3 ATRs) | 41.80 |
| Upper Bollinger Bands | 45.23 |
| Lower Bollinger Band | 37.72 |
| Percent B (%b) | -0.02 |
| BandWidth | 18.11 |
| MACD Line | -1.43 |
| MACD Signal Line | -0.92 |
| MACD Histogram | -0.5163 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 40.10 | ||||
| Resistance 3 (R3) | 40.13 | 39.33 | 39.68 | ||
| Resistance 2 (R2) | 39.33 | 38.69 | 39.31 | 39.54 | |
| Resistance 1 (R1) | 38.46 | 38.29 | 38.06 | 38.43 | 39.40 |
| Pivot Point | 37.65 | 37.65 | 37.45 | 37.64 | 37.65 |
| Support 1 (S1) | 36.79 | 37.02 | 36.38 | 36.75 | 35.78 |
| Support 2 (S2) | 35.98 | 36.62 | 35.97 | 35.64 | |
| Support 3 (S3) | 35.11 | 35.98 | 35.50 | ||
| Support 4 (S4) | 35.08 |
